HomeINZY • NASDAQ
add
Inozyme Pharma Inc
Previous close
$4.65
Day range
$4.68 - $4.84
Year range
$2.69 - $7.80
Market cap
292.80M USD
Avg Volume
841.50K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 22.81M | 16.77% |
Net income | -21.54M | -16.18% |
Net profit margin | — | — |
Earnings per share | -0.35 | -12.90% |
EBITDA | -22.60M | -16.88% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 188.59M | 47.49% |
Total assets | 200.85M | 44.29% |
Total liabilities | 60.37M | 190.22% |
Total equity | 140.48M | — |
Shares outstanding | 61.77M | — |
Price to book | 2.05 | — |
Return on assets | -28.05% | — |
Return on capital | -29.90% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -21.54M | -16.18% |
Cash from operations | -18.49M | -28.38% |
Cash from investing | -6.47M | -301.06% |
Cash from financing | 12.52M | — |
Net change in cash | -12.31M | -10.58% |
Free cash flow | -10.11M | -29.15% |
About
Founded
2015
Headquarters
Website
Employees
59